【摘要】：正2017年8月1日,JAMA在線發(fā)表了由北京大學(xué)第一醫(yī)院腎臟內(nèi)科張宏教授牽頭的國(guó)際多中心研究中期分析結(jié)果[Lv J,Zhang H,Wong MG,et al.Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy:the testing randomized clinical trial.JAMA,2017,318(5):432-442]。該研究入組了262例尿蛋白大于1 g/d的IgA腎病患者,隨機(jī)分為甲基強(qiáng)的松龍和安慰劑組,所有患者均按照目前改善全球腎臟病預(yù)后組織(Kidney Disease:Impro-
[Abstract]:On August 1, 2017, Jama published online the results of a mid-term analysis of the international multi-center study led by Professor Zhang Hong of the Department of Renal Medicine, first Hospital of Peking University [Lv Jang Zhang Heng Wong al.Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy:the testing randomized clinical trial.JAMAN 2017318 (5): 432-442]. The study included 262 patients with IgA nephropathy whose urine protein was greater than 1 g / d, randomly divided into methylprednisolone and placebo groups.
【作者單位】： 北京大學(xué)第一醫(yī)院腎臟內(nèi)科;
【分類號(hào)】：R692.31

【相似文獻(xiàn)】

相關(guān)期刊論文 前1條

1 冒國(guó)光;章輝;張道友;吳彩玲;周巧玲;敖翔;鄧聲莉;胡成平;孟婕;蘇曉麗;張征宇;施毅;鄧桂興;呂華沖;李萇清;王霆;;注射用哌拉西林/舒巴坦治療呼吸和泌尿系統(tǒng)感染多中心臨床研究[J];藥學(xué)與臨床研究;2011年01期

，

本文編號(hào)：2170194